Edition:
India

Eleven Biotherapeutics Inc (EBIO.OQ)

EBIO.OQ on NASDAQ Stock Exchange Global Market

0.93USD
16 Feb 2018
Change (% chg)

$0.03 (+3.22%)
Prev Close
$0.90
Open
$0.90
Day's High
$0.97
Day's Low
$0.90
Volume
24,534
Avg. Vol
168,855
52-wk High
$2.53
52-wk Low
$0.63

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.369
Jun '17 0.00 -0.296
Mar '17 0.43 -0.246
FY 2016 Dec '16 0.82 -0.145
Sep '16 28.65 0.910
Jun '16 0.28 -0.327
Mar '16 0.23 -0.386
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 2,928.38 182.20 --
EPS (TTM) % 104.94 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Eleven Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -7.88 -11.06 37 --
13 Week -0.65 -5.49 96 --
26 Week -23.23 -29.07 51 --
52 Week -38.21 -47.63 46 --
YTD -20.42 -30.11 51 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 46.64%
# of Holders: 33
Total Shares Held: 14,847,161
3 Mo. Net Change: 8,424,455
# New Positions: 5
# Closed Positions: 3
# Increased Positions: 12
# Reduced Positions: 5
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.